“Early initiation of high-efficacy therapies for the treatment of relapsing multiple sclerosis has been shown to improve long-term outcomes versus escalating from lower efficacy therapies,” researcher Ludwig Kappos, MD, from University Hospital Basel, said in a statemen...
MS,balancingearlydiagnosiswiththeneedtoavoid false-positivediagnosis.TheCriteriaformallyincorpo- ratedmagneticresonanceimaging(MRI)intothewell- establisheddiagnosticworkupthatfocusesondetailed neurologicalhistoryandexaminationandavarietyof paraclinicallaboratoryexaminations.Componentsof ...
There are no tests to diagnose MS, but doctors look for similar signs and symptoms. While there is no known cure for the disease, symptoms can be treated with hopes of preventing them and slowing the progression of the disease,according to the Mayo Clinic. Some peop...
a high risk of secondary immune-mediated disorders and infections [32] limits the widespread use of immune reconstitution drugs, despite their prolonged effectiveness in pulse therapies. This explains their low proportion of use in the early years after diagnosis, where the symptoms could be relativel...
Stage I AVMs initially present with dermatologic symptoms, such as skin that possesses a cutaneous blush or warmth resembling a port wine stain [11]. Stage II AVMs present with more noticeable findings, such as bruits or thrills caused by circulation within the nidus as well as the presence ...
Neurology 68 (2007): 1183 - 1187. [4]https://www.mayoclinic.org/zh-hans/diseases-conditions/angelman-syndrome/symptoms-causes/syc-20355621 [5]https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-rett-syndrome [6]https://daybue.com/about-daybue/...
The presence of at least some tau pathology in the hippocampus of normal subjects is consistent with work by others [41], and could potentially indicate either pre-clinical AD or early neurofibrillary tangle predominant dementia (NFTD). However, in the absence of clinical symptoms, it is not ...